(Q34621110)

3 August 2017

1 reference

title

Mometasone furoate in children with mild to moderate persistent asthma: a review of the evidence (English)

1 reference

3 August 2017

0 references

Henry Milgrom

1

1 reference

3 August 2017

1 August 2010

1 reference

3 August 2017

1 reference

3 August 2017

12

1 reference

3 August 2017

4

1 reference

3 August 2017

213-221

1 reference

https://scigraph.springernature.com/pub.10.2165/11316220-000000000-00000

3 August 2017

0 references

cites work

Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11316220-000000000-00000

Once-daily evening administration of mometasone furoate in asthma treatment initiation

21 January 2018

1 reference

12 December 2020

Long-term safety of mometasone furoate administered via a dry powder inhaler in children: Results of an open-label study comparing mometasone furoate with beclomethasone dipropionate in children with persistent asthma

1 reference

12 December 2020

Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study.

1 reference

12 December 2020

Relationship of adherence to pediatric asthma morbidity among inner-city children

1 reference

12 December 2020

Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler

1 reference

12 December 2020

Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial

1 reference

12 December 2020

Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler

1 reference

12 December 2020

Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator

1 reference

12 December 2020

Drug delivery performance of the mometasone furoate dry powder inhaler

1 reference

12 December 2020

Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate

1 reference

12 December 2020

Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma

1 reference

12 December 2020

A systematic review of the associations between dose regimens and medication compliance

1 reference

12 December 2020

Dry powder inhalers: which factors determine the frequency of handling errors?

1 reference

12 December 2020

Comparable morning versus evening administration of once-daily mometasone furoate dry powder inhaler

1 reference

12 December 2020

Compliance, adherence, and concordance: implications for asthma treatment

1 reference

12 December 2020

Overcoming barriers to nonadherence in asthma treatment

1 reference

12 December 2020

Effect of therapeutic doses of mometasone furoate on cortisol levels in children with mild asthma

1 reference

12 December 2020

Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate

1 reference

12 December 2020

Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.

1 reference

12 December 2020

Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma

1 reference

12 December 2020

Asthma treatment needs: a comparison of patients' and health care professionals' perceptions

1 reference

12 December 2020

Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler.

1 reference

12 December 2020

Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma

1 reference

12 December 2020

Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma

1 reference

12 December 2020

Noncompliance and treatment failure in children with asthma

1 reference

12 December 2020

Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma

1 reference

12 December 2020

Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma

1 reference

12 December 2020

Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses.

1 reference

12 December 2020

Barriers to treatment adherence for children with cystic fibrosis and asthma: what gets in the way?

1 reference

12 December 2020

10.2165/11316220-000000000-00000

Identifiers

DOI

1 reference

PubMed ID

20593906

Dimensions Publication ID

3 August 2017

1012505030

0 references

Fatcat ID

release_b34yoon6yvd6llndpyxve66mgy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/b34yoon6yvd6llndpyxve66mgy

24 November 2022

mapped directly with Wikidata item

PubMed ID

20593906

1 reference

PubMed ID

20593906